Hbk Investments L P Catalent, Inc. Transaction History

Hbk Investments L P

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	N/A	-2,875,001 Closed	0 $0
Q2 2025 Aug 13, 2025	SELL	N/A	-1,275,809 Closed	0 $0
Q3 2024 Nov 14, 2025	BUY	$56.16 - $60.96 $161 Million - $175 Million	2,875,001 New	2,875,001 $174 Million
Q2 2024 Aug 13, 2025	BUY	$53.58 - $57.02 $68.4 Million - $72.7 Million	1,275,809 New	1,275,809 $71.7 Million
Q1 2024 May 15, 2025	BUY	$42.56 - $59.82 $42.6 Million - $59.9 Million	1,002,084 New	1,002,084 $56.6 Million

Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $3.19 Million - $6.73 Million	100,001 New	100,001 $4.34 Million
Q4 2017 Feb 14, 2018	SELL	$37.27 - $43.02 $4.55 Million - $5.25 Million	-122,081 Reduced 92.08%	10,500 $431,000
Q3 2017 Nov 14, 2017	BUY	$33.75 - $41.67 $4.47 Million - $5.52 Million	132,581	132,581 $5.29 Million

16.5M

10.7K

4.5K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.